Lauren Santye, Assistant Editor

Rinku Patel, PharmD, RPh, CEO and founder of KloudScript, discusses the impact of direct and indirect remuneration (DIR) fees.

Housing Opportunities for Persons With AIDS program awarded $320.4 million to qualifying states and local jurisdictions.

Top news of the day from across the healthcare landscape.

Top news of the day from across the health care landscape.

Study findings highlight the importance of community-based health interventions that target cancer prevention.

Approval sought for vemurafenib (Zelboraf) to treat Erdheim-Chester disease with BRAF V600 mutation.

Physical training further minimizes brain shrinkage in MS patients already receiving medication.

Partner violence negatively impacts the ability of women with HIV to adhere to antiretrovirals.

Top news of the day from across the health care landscape.

Heplisav-B aims to boost a patient’s own immune response to fight off HBV.

Top news of the day from across the health care landscape.

The study is the first to evaluate VRC01 antibody in patients who started antiretroviral therapy during acute HIV infection.

Maviret is an 8-week treatment that combines 2 distinct antiviral agents.

If approved, Xeljanz will be the first Janus kinase inhibitor for psoriatic arthritis.

Pilot project to bring pre-exposure prophylaxis to the Philippines for the first time.

Top news of the day from across the health care landscape.

Durvalumab is indicated to treat patients with locally-advanced, unresectable non-small cell lung cancer.

Targeting cell mutations could disrupt tumor cell growth without harming non-cancerous cells.

Although the FDA is not bound by the recommendation of the committee, their advice is taken into consideration.

Mavyret approved for chronic hepatitis C virus genotypes 1-6 without cirrhosis or with mild cirrhosis.

Combination therapy cuts standard HCV treatment regimen from 12 weeks to 8 weeks.

An approval decision for Alecensa is expected by November 30, 2017.

Sirukumab is designed to treat adults with moderately-to-severely active rheumatoid arthritis.

Glycemic control may reduce cardiovascular disease-related mortality among older patients with type 1 diabetes.

Research advances hunt for a safe and effective preventative HIV vaccine.

Vyxeos is a combination chemotherapy that treats a pair of high-risk subsets of acute myeloid leukemia.

Vyxeos is indicated to treat newly diagnosed therapy-related AML or AML with myelodysplasia-related changes.

The approach only targets metastatic tissue, reducing negative adverse events associated with chemotherapy.

Top news of the day from across the health care landscape.

HEV is reemerging as a zoonotic virus, with individuals becoming infected via pigs and pork products.